World Scientists and Doctors have been researching and working to develop vaccine for cure of coronavirus.
BBC reports that Inovio’s lab in San Diego, scientists are using a
relatively new type of DNA technology to develop a potential vaccine known as “INO-4800” which will enter human trials in early summer.
According to Kate Broderick, senior vice-president of research and development at Inovio, “Once China had provided the DNA sequence of this virus, we were able to put it through our lab’s computer technology and design a vaccine within three hours.
“Our DNA medicine vaccines are novel in that they use DNA sequences from the virus to target specific parts of the pathogen which we believe the body will mount the strongest response to.
“We then use the patient’s own cells to become a factory for the vaccine, strengthening the body’s own natural response mechanisms.”
Furthermore, The University of Queensland is said have been working on a vaccine known as “molecular clamp”.
Other organizations who are out for the solution of the virus include Moderna Inc in Massachusetts, in alliance with the US National Institute of Allergy and Infectious Diseases for the research.
Johnson (JNJ) and GlaxoSmithKline (GSK).
Biotech company known as AbbVie (ABBV) has brought results for treating the Wuhan coronavirus with a mixture of two of its HIV medications and Tamiflu.
CNN reports that Gilead Sciences, a biopharmaceutical firm is also working on vaccines with an experimental drug called “remdesivir” that is used to treat the Ebola virus.
Gilead science said that remdesivir has indicated some success as it has been used for treatment of MERS and SARS, two viruses similar to the Wuhan coronavirus, in animals.
Remdesivir has also been used for emergency treatment of patients with Ebola in the past years.
The vaccine may take a year for before it will be available according to Dr. Anthony Fauci, director of the US National Institutes of Allergy and Infectious Diseases.